HEADER HYDROLASE/INHIBITOR 24-JUN-21 7R7D TITLE STRUCTURE OF HUMAN SHP2 IN COMPLEX WITH COMPOUND 22 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 11; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PROTEIN-TYROSINE PHOSPHATASE 1D,PTP-1D,PROTEIN-TYROSINE COMPND 5 PHOSPHATASE 2C,PTP-2C,SH-PTP2,SHP2,SH-PTP3; COMPND 6 EC: 3.1.3.48; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTPN11, PTP2C, SHPTP2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PHOSPHATASE, INHIBITOR, SHP2, ALLOSTERIC, HYDROLASE, HYDROLASE- KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR P.G.LEONARD,J.CROSS REVDAT 3 18-OCT-23 7R7D 1 REMARK REVDAT 2 10-NOV-21 7R7D 1 JRNL REVDAT 1 27-OCT-21 7R7D 0 JRNL AUTH B.CZAKO,Y.SUN,T.MCAFOOS,J.B.CROSS,P.G.LEONARD,J.P.BURKE, JRNL AUTH 2 C.L.CARROLL,N.FENG,A.L.HARRIS,Y.JIANG,Z.KANG,J.J.KOVACS, JRNL AUTH 3 P.MANDAL,B.A.MEYERS,F.MSEEH,C.A.PARKER,S.S.YU,C.C.WILLIAMS, JRNL AUTH 4 Q.WU,M.E.DI FRANCESCO,G.DRAETTA,T.HEFFERNAN,J.R.MARSZALEK, JRNL AUTH 5 N.E.KOHL,P.JONES JRNL TITL DISCOVERY OF 6-[(3 S ,4 S JRNL TITL 2 )-4-AMINO-3-METHYL-2-OXA-8-AZASPIRO[4.5]DECAN-8-YL]-3-(2, JRNL TITL 3 3-DICHLOROPHENYL)-2-METHYL-3,4-DIHYDROPYRIMIDIN-4-ONE JRNL TITL 4 (IACS-15414), A POTENT AND ORALLY BIOAVAILABLE SHP2 JRNL TITL 5 INHIBITOR. JRNL REF J.MED.CHEM. V. 64 15141 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34643390 JRNL DOI 10.1021/ACS.JMEDCHEM.1C01132 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.1-4122-000 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.98 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 3 NUMBER OF REFLECTIONS : 30514 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.880 REMARK 3 FREE R VALUE TEST SET COUNT : 1489 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.9800 - 5.7800 1.00 2955 154 0.1871 0.2195 REMARK 3 2 5.7800 - 4.5900 1.00 2781 161 0.1697 0.2254 REMARK 3 3 4.5900 - 4.0100 1.00 2747 172 0.1563 0.2192 REMARK 3 4 4.0100 - 3.6400 0.99 2743 131 0.1813 0.2007 REMARK 3 5 3.6400 - 3.3800 0.98 2714 130 0.2206 0.3045 REMARK 3 6 3.3800 - 3.1800 0.97 2649 129 0.2206 0.2751 REMARK 3 7 3.1800 - 3.0200 0.95 2582 128 0.2426 0.3367 REMARK 3 8 3.0200 - 2.8900 0.92 2498 134 0.2774 0.3736 REMARK 3 9 2.8900 - 2.7800 0.92 2490 125 0.2836 0.3709 REMARK 3 10 2.7800 - 2.6800 0.89 2465 112 0.2647 0.3505 REMARK 3 11 2.6800 - 2.6000 0.89 2401 113 0.2575 0.3287 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.380 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.200 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 40.97 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.47 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 8188 REMARK 3 ANGLE : 0.483 11039 REMARK 3 CHIRALITY : 0.042 1182 REMARK 3 PLANARITY : 0.004 1419 REMARK 3 DIHEDRAL : 14.426 3075 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7R7D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JUN-21. REMARK 100 THE DEPOSITION ID IS D_1000257755. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-OCT-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.32 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30616 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 49.250 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 200 DATA REDUNDANCY : 7.300 REMARK 200 R MERGE (I) : 0.18700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.72 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.3 REMARK 200 DATA REDUNDANCY IN SHELL : 7.30 REMARK 200 R MERGE FOR SHELL (I) : 1.17000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.7.16 REMARK 200 STARTING MODEL: 2SHP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 300 MM POTASSIUM FORMATE, 14% W/V REMARK 280 PEG3350, PH 8.0, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.57500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 109.47000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.64000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 109.47000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.57500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.64000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -5 REMARK 465 ALA A -4 REMARK 465 MET A -3 REMARK 465 ALA A -2 REMARK 465 ASP A -1 REMARK 465 ILE A 0 REMARK 465 MET A 1 REMARK 465 THR A 2 REMARK 465 LYS A 91 REMARK 465 ASN A 92 REMARK 465 GLY A 93 REMARK 465 ASP A 156 REMARK 465 LYS A 157 REMARK 465 GLY A 158 REMARK 465 GLU A 159 REMARK 465 SER A 160 REMARK 465 ASN A 161 REMARK 465 ALA A 237 REMARK 465 GLU A 238 REMARK 465 THR A 239 REMARK 465 THR A 240 REMARK 465 ASP A 241 REMARK 465 LYS A 242 REMARK 465 VAL A 243 REMARK 465 LYS A 244 REMARK 465 GLY A 295 REMARK 465 ASP A 296 REMARK 465 PRO A 297 REMARK 465 ASN A 298 REMARK 465 GLU A 299 REMARK 465 PRO A 300 REMARK 465 GLU A 313 REMARK 465 PHE A 314 REMARK 465 GLU A 315 REMARK 465 THR A 316 REMARK 465 LYS A 317 REMARK 465 CYS A 318 REMARK 465 ASN A 319 REMARK 465 ASN A 320 REMARK 465 SER A 321 REMARK 465 LYS A 322 REMARK 465 PRO A 323 REMARK 465 GLN A 526 REMARK 465 ARG A 527 REMARK 465 ARG A 528 REMARK 465 ILE A 529 REMARK 465 GLU A 530 REMARK 465 GLY B -5 REMARK 465 ALA B -4 REMARK 465 MET B -3 REMARK 465 ALA B -2 REMARK 465 ASP B -1 REMARK 465 ILE B 0 REMARK 465 MET B 1 REMARK 465 THR B 2 REMARK 465 ASP B 156 REMARK 465 LYS B 157 REMARK 465 GLY B 158 REMARK 465 GLU B 159 REMARK 465 ALA B 237 REMARK 465 GLU B 238 REMARK 465 THR B 239 REMARK 465 THR B 240 REMARK 465 ASP B 241 REMARK 465 LYS B 242 REMARK 465 VAL B 243 REMARK 465 ASP B 296 REMARK 465 PRO B 297 REMARK 465 ASN B 298 REMARK 465 GLU B 299 REMARK 465 PRO B 300 REMARK 465 VAL B 301 REMARK 465 GLU B 313 REMARK 465 PHE B 314 REMARK 465 GLU B 315 REMARK 465 THR B 316 REMARK 465 LYS B 317 REMARK 465 CYS B 318 REMARK 465 ASN B 319 REMARK 465 ASN B 320 REMARK 465 SER B 321 REMARK 465 LYS B 322 REMARK 465 PRO B 323 REMARK 465 GLN B 526 REMARK 465 ARG B 527 REMARK 465 ARG B 528 REMARK 465 ILE B 529 REMARK 465 GLU B 530 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 301 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 4 -4.33 69.62 REMARK 500 HIS A 84 63.65 -118.46 REMARK 500 VAL A 95 108.20 65.85 REMARK 500 LEU A 177 18.89 59.42 REMARK 500 LYS A 213 -81.61 -95.99 REMARK 500 GLU A 225 58.26 -98.69 REMARK 500 ARG A 265 44.44 -140.51 REMARK 500 ARG A 362 -97.09 53.89 REMARK 500 ARG A 421 -4.93 -140.92 REMARK 500 THR A 422 41.56 -86.22 REMARK 500 ASP A 451 -5.06 -174.17 REMARK 500 CYS A 459 -107.62 -137.29 REMARK 500 SER A 460 -66.08 -108.15 REMARK 500 VAL A 505 107.10 63.49 REMARK 500 HIS B 84 62.57 -115.50 REMARK 500 HIS B 116 22.93 -77.03 REMARK 500 ASN B 161 -55.54 -128.28 REMARK 500 GLU B 176 70.65 55.38 REMARK 500 LYS B 213 -86.00 -90.17 REMARK 500 GLU B 225 35.44 -91.56 REMARK 500 GLU B 272 9.87 -68.49 REMARK 500 TYR B 375 -1.10 71.39 REMARK 500 ASP B 451 40.39 35.57 REMARK 500 CYS B 459 -112.33 -138.85 REMARK 500 SER B 460 -75.22 -99.70 REMARK 500 ASP B 485 38.36 -96.13 REMARK 500 VAL B 505 105.51 63.82 REMARK 500 THR B 524 39.20 -84.67 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6WU8 RELATED DB: PDB REMARK 900 6WU8 CONTAINS THE SAME PROTEIN COMPLEXED WITH IACS-13909 INHIBITOR DBREF 7R7D A 1 530 UNP Q06124 PTN11_HUMAN 1 530 DBREF 7R7D B 1 530 UNP Q06124 PTN11_HUMAN 1 530 SEQADV 7R7D GLY A -5 UNP Q06124 EXPRESSION TAG SEQADV 7R7D ALA A -4 UNP Q06124 EXPRESSION TAG SEQADV 7R7D MET A -3 UNP Q06124 EXPRESSION TAG SEQADV 7R7D ALA A -2 UNP Q06124 EXPRESSION TAG SEQADV 7R7D ASP A -1 UNP Q06124 EXPRESSION TAG SEQADV 7R7D ILE A 0 UNP Q06124 EXPRESSION TAG SEQADV 7R7D GLY B -5 UNP Q06124 EXPRESSION TAG SEQADV 7R7D ALA B -4 UNP Q06124 EXPRESSION TAG SEQADV 7R7D MET B -3 UNP Q06124 EXPRESSION TAG SEQADV 7R7D ALA B -2 UNP Q06124 EXPRESSION TAG SEQADV 7R7D ASP B -1 UNP Q06124 EXPRESSION TAG SEQADV 7R7D ILE B 0 UNP Q06124 EXPRESSION TAG SEQRES 1 A 536 GLY ALA MET ALA ASP ILE MET THR SER ARG ARG TRP PHE SEQRES 2 A 536 HIS PRO ASN ILE THR GLY VAL GLU ALA GLU ASN LEU LEU SEQRES 3 A 536 LEU THR ARG GLY VAL ASP GLY SER PHE LEU ALA ARG PRO SEQRES 4 A 536 SER LYS SER ASN PRO GLY ASP PHE THR LEU SER VAL ARG SEQRES 5 A 536 ARG ASN GLY ALA VAL THR HIS ILE LYS ILE GLN ASN THR SEQRES 6 A 536 GLY ASP TYR TYR ASP LEU TYR GLY GLY GLU LYS PHE ALA SEQRES 7 A 536 THR LEU ALA GLU LEU VAL GLN TYR TYR MET GLU HIS HIS SEQRES 8 A 536 GLY GLN LEU LYS GLU LYS ASN GLY ASP VAL ILE GLU LEU SEQRES 9 A 536 LYS TYR PRO LEU ASN CYS ALA ASP PRO THR SER GLU ARG SEQRES 10 A 536 TRP PHE HIS GLY HIS LEU SER GLY LYS GLU ALA GLU LYS SEQRES 11 A 536 LEU LEU THR GLU LYS GLY LYS HIS GLY SER PHE LEU VAL SEQRES 12 A 536 ARG GLU SER GLN SER HIS PRO GLY ASP PHE VAL LEU SER SEQRES 13 A 536 VAL ARG THR GLY ASP ASP LYS GLY GLU SER ASN ASP GLY SEQRES 14 A 536 LYS SER LYS VAL THR HIS VAL MET ILE ARG CYS GLN GLU SEQRES 15 A 536 LEU LYS TYR ASP VAL GLY GLY GLY GLU ARG PHE ASP SER SEQRES 16 A 536 LEU THR ASP LEU VAL GLU HIS TYR LYS LYS ASN PRO MET SEQRES 17 A 536 VAL GLU THR LEU GLY THR VAL LEU GLN LEU LYS GLN PRO SEQRES 18 A 536 LEU ASN THR THR ARG ILE ASN ALA ALA GLU ILE GLU SER SEQRES 19 A 536 ARG VAL ARG GLU LEU SER LYS LEU ALA GLU THR THR ASP SEQRES 20 A 536 LYS VAL LYS GLN GLY PHE TRP GLU GLU PHE GLU THR LEU SEQRES 21 A 536 GLN GLN GLN GLU CYS LYS LEU LEU TYR SER ARG LYS GLU SEQRES 22 A 536 GLY GLN ARG GLN GLU ASN LYS ASN LYS ASN ARG TYR LYS SEQRES 23 A 536 ASN ILE LEU PRO PHE ASP HIS THR ARG VAL VAL LEU HIS SEQRES 24 A 536 ASP GLY ASP PRO ASN GLU PRO VAL SER ASP TYR ILE ASN SEQRES 25 A 536 ALA ASN ILE ILE MET PRO GLU PHE GLU THR LYS CYS ASN SEQRES 26 A 536 ASN SER LYS PRO LYS LYS SER TYR ILE ALA THR GLN GLY SEQRES 27 A 536 CYS LEU GLN ASN THR VAL ASN ASP PHE TRP ARG MET VAL SEQRES 28 A 536 PHE GLN GLU ASN SER ARG VAL ILE VAL MET THR THR LYS SEQRES 29 A 536 GLU VAL GLU ARG GLY LYS SER LYS CYS VAL LYS TYR TRP SEQRES 30 A 536 PRO ASP GLU TYR ALA LEU LYS GLU TYR GLY VAL MET ARG SEQRES 31 A 536 VAL ARG ASN VAL LYS GLU SER ALA ALA HIS ASP TYR THR SEQRES 32 A 536 LEU ARG GLU LEU LYS LEU SER LYS VAL GLY GLN GLY ASN SEQRES 33 A 536 THR GLU ARG THR VAL TRP GLN TYR HIS PHE ARG THR TRP SEQRES 34 A 536 PRO ASP HIS GLY VAL PRO SER ASP PRO GLY GLY VAL LEU SEQRES 35 A 536 ASP PHE LEU GLU GLU VAL HIS HIS LYS GLN GLU SER ILE SEQRES 36 A 536 MET ASP ALA GLY PRO VAL VAL VAL HIS CYS SER ALA GLY SEQRES 37 A 536 ILE GLY ARG THR GLY THR PHE ILE VAL ILE ASP ILE LEU SEQRES 38 A 536 ILE ASP ILE ILE ARG GLU LYS GLY VAL ASP CYS ASP ILE SEQRES 39 A 536 ASP VAL PRO LYS THR ILE GLN MET VAL ARG SER GLN ARG SEQRES 40 A 536 SER GLY MET VAL GLN THR GLU ALA GLN TYR ARG PHE ILE SEQRES 41 A 536 TYR MET ALA VAL GLN HIS TYR ILE GLU THR LEU GLN ARG SEQRES 42 A 536 ARG ILE GLU SEQRES 1 B 536 GLY ALA MET ALA ASP ILE MET THR SER ARG ARG TRP PHE SEQRES 2 B 536 HIS PRO ASN ILE THR GLY VAL GLU ALA GLU ASN LEU LEU SEQRES 3 B 536 LEU THR ARG GLY VAL ASP GLY SER PHE LEU ALA ARG PRO SEQRES 4 B 536 SER LYS SER ASN PRO GLY ASP PHE THR LEU SER VAL ARG SEQRES 5 B 536 ARG ASN GLY ALA VAL THR HIS ILE LYS ILE GLN ASN THR SEQRES 6 B 536 GLY ASP TYR TYR ASP LEU TYR GLY GLY GLU LYS PHE ALA SEQRES 7 B 536 THR LEU ALA GLU LEU VAL GLN TYR TYR MET GLU HIS HIS SEQRES 8 B 536 GLY GLN LEU LYS GLU LYS ASN GLY ASP VAL ILE GLU LEU SEQRES 9 B 536 LYS TYR PRO LEU ASN CYS ALA ASP PRO THR SER GLU ARG SEQRES 10 B 536 TRP PHE HIS GLY HIS LEU SER GLY LYS GLU ALA GLU LYS SEQRES 11 B 536 LEU LEU THR GLU LYS GLY LYS HIS GLY SER PHE LEU VAL SEQRES 12 B 536 ARG GLU SER GLN SER HIS PRO GLY ASP PHE VAL LEU SER SEQRES 13 B 536 VAL ARG THR GLY ASP ASP LYS GLY GLU SER ASN ASP GLY SEQRES 14 B 536 LYS SER LYS VAL THR HIS VAL MET ILE ARG CYS GLN GLU SEQRES 15 B 536 LEU LYS TYR ASP VAL GLY GLY GLY GLU ARG PHE ASP SER SEQRES 16 B 536 LEU THR ASP LEU VAL GLU HIS TYR LYS LYS ASN PRO MET SEQRES 17 B 536 VAL GLU THR LEU GLY THR VAL LEU GLN LEU LYS GLN PRO SEQRES 18 B 536 LEU ASN THR THR ARG ILE ASN ALA ALA GLU ILE GLU SER SEQRES 19 B 536 ARG VAL ARG GLU LEU SER LYS LEU ALA GLU THR THR ASP SEQRES 20 B 536 LYS VAL LYS GLN GLY PHE TRP GLU GLU PHE GLU THR LEU SEQRES 21 B 536 GLN GLN GLN GLU CYS LYS LEU LEU TYR SER ARG LYS GLU SEQRES 22 B 536 GLY GLN ARG GLN GLU ASN LYS ASN LYS ASN ARG TYR LYS SEQRES 23 B 536 ASN ILE LEU PRO PHE ASP HIS THR ARG VAL VAL LEU HIS SEQRES 24 B 536 ASP GLY ASP PRO ASN GLU PRO VAL SER ASP TYR ILE ASN SEQRES 25 B 536 ALA ASN ILE ILE MET PRO GLU PHE GLU THR LYS CYS ASN SEQRES 26 B 536 ASN SER LYS PRO LYS LYS SER TYR ILE ALA THR GLN GLY SEQRES 27 B 536 CYS LEU GLN ASN THR VAL ASN ASP PHE TRP ARG MET VAL SEQRES 28 B 536 PHE GLN GLU ASN SER ARG VAL ILE VAL MET THR THR LYS SEQRES 29 B 536 GLU VAL GLU ARG GLY LYS SER LYS CYS VAL LYS TYR TRP SEQRES 30 B 536 PRO ASP GLU TYR ALA LEU LYS GLU TYR GLY VAL MET ARG SEQRES 31 B 536 VAL ARG ASN VAL LYS GLU SER ALA ALA HIS ASP TYR THR SEQRES 32 B 536 LEU ARG GLU LEU LYS LEU SER LYS VAL GLY GLN GLY ASN SEQRES 33 B 536 THR GLU ARG THR VAL TRP GLN TYR HIS PHE ARG THR TRP SEQRES 34 B 536 PRO ASP HIS GLY VAL PRO SER ASP PRO GLY GLY VAL LEU SEQRES 35 B 536 ASP PHE LEU GLU GLU VAL HIS HIS LYS GLN GLU SER ILE SEQRES 36 B 536 MET ASP ALA GLY PRO VAL VAL VAL HIS CYS SER ALA GLY SEQRES 37 B 536 ILE GLY ARG THR GLY THR PHE ILE VAL ILE ASP ILE LEU SEQRES 38 B 536 ILE ASP ILE ILE ARG GLU LYS GLY VAL ASP CYS ASP ILE SEQRES 39 B 536 ASP VAL PRO LYS THR ILE GLN MET VAL ARG SER GLN ARG SEQRES 40 B 536 SER GLY MET VAL GLN THR GLU ALA GLN TYR ARG PHE ILE SEQRES 41 B 536 TYR MET ALA VAL GLN HIS TYR ILE GLU THR LEU GLN ARG SEQRES 42 B 536 ARG ILE GLU HET 37I A 601 26 HET 37I B 601 26 HET PG4 B 602 13 HETNAM 37I 4-[6-(4-AMINO-4-METHYLPIPERIDIN-1-YL)-1H-PYRAZOLO[3,4- HETNAM 2 37I B]PYRAZIN-3-YL]-3-CHLORO-N-METHYLPYRIDIN-2-AMINE HETNAM PG4 TETRAETHYLENE GLYCOL FORMUL 3 37I 2(C17 H21 CL N8) FORMUL 5 PG4 C8 H18 O5 FORMUL 6 HOH *229(H2 O) HELIX 1 AA1 THR A 12 ARG A 23 1 12 HELIX 2 AA2 THR A 73 HIS A 84 1 12 HELIX 3 AA3 SER A 118 LYS A 129 1 12 HELIX 4 AA4 SER A 189 LYS A 198 1 10 HELIX 5 AA5 GLU A 225 LYS A 235 1 11 HELIX 6 AA6 GLY A 246 GLN A 257 1 12 HELIX 7 AA7 GLU A 258 LEU A 262 5 5 HELIX 8 AA8 ARG A 265 ARG A 270 1 6 HELIX 9 AA9 GLN A 271 ASN A 277 5 7 HELIX 10 AB1 PHE A 285 ARG A 289 5 5 HELIX 11 AB2 THR A 337 GLU A 348 1 12 HELIX 12 AB3 PRO A 432 SER A 448 1 17 HELIX 13 AB4 GLY A 464 GLY A 483 1 20 HELIX 14 AB5 ASP A 489 SER A 499 1 11 HELIX 15 AB6 THR A 507 THR A 524 1 18 HELIX 16 AB7 THR B 12 ARG B 23 1 12 HELIX 17 AB8 THR B 73 HIS B 84 1 12 HELIX 18 AB9 SER B 118 LYS B 129 1 12 HELIX 19 AC1 SER B 189 ASN B 200 1 12 HELIX 20 AC2 GLU B 225 SER B 234 1 10 HELIX 21 AC3 GLN B 245 GLN B 257 1 13 HELIX 22 AC4 GLU B 258 LEU B 262 5 5 HELIX 23 AC5 ARG B 265 ARG B 270 1 6 HELIX 24 AC6 GLN B 271 ASN B 277 5 7 HELIX 25 AC7 PHE B 285 HIS B 287 5 3 HELIX 26 AC8 LEU B 334 ASN B 336 5 3 HELIX 27 AC9 THR B 337 GLU B 348 1 12 HELIX 28 AD1 PRO B 432 ILE B 449 1 18 HELIX 29 AD2 GLY B 464 GLY B 483 1 20 HELIX 30 AD3 ASP B 489 SER B 499 1 11 HELIX 31 AD4 THR B 507 THR B 524 1 18 SHEET 1 AA1 6 LYS A 70 PHE A 71 0 SHEET 2 AA1 6 TYR A 63 LEU A 65 -1 N TYR A 63 O PHE A 71 SHEET 3 AA1 6 ALA A 50 GLN A 57 -1 N GLN A 57 O ASP A 64 SHEET 4 AA1 6 ASP A 40 ARG A 47 -1 N PHE A 41 O ILE A 56 SHEET 5 AA1 6 SER A 28 SER A 34 -1 N ARG A 32 O THR A 42 SHEET 6 AA1 6 TYR A 100 PRO A 101 1 O TYR A 100 N PHE A 29 SHEET 1 AA2 5 PHE A 113 HIS A 114 0 SHEET 2 AA2 5 PHE A 135 GLU A 139 1 O VAL A 137 N HIS A 114 SHEET 3 AA2 5 PHE A 147 THR A 153 -1 O SER A 150 N LEU A 136 SHEET 4 AA2 5 LYS A 166 GLN A 175 -1 O ILE A 172 N PHE A 147 SHEET 5 AA2 5 LYS A 178 ASP A 180 -1 O LYS A 178 N GLN A 175 SHEET 1 AA3 2 MET A 202 VAL A 203 0 SHEET 2 AA3 2 VAL A 209 LEU A 210 -1 O LEU A 210 N MET A 202 SHEET 1 AA4 2 ILE A 221 ASN A 222 0 SHEET 2 AA4 2 ASP A 487 ILE A 488 -1 O ILE A 488 N ILE A 221 SHEET 1 AA5 8 ALA A 307 ILE A 310 0 SHEET 2 AA5 8 TYR A 327 THR A 330 -1 O TYR A 327 N ILE A 310 SHEET 3 AA5 8 VAL A 455 HIS A 458 1 O VAL A 457 N ILE A 328 SHEET 4 AA5 8 VAL A 352 MET A 355 1 N VAL A 354 O VAL A 456 SHEET 5 AA5 8 ARG A 413 PHE A 420 1 O TYR A 418 N ILE A 353 SHEET 6 AA5 8 TYR A 396 LYS A 405 -1 N LEU A 401 O VAL A 415 SHEET 7 AA5 8 MET A 383 ALA A 392 -1 N SER A 391 O LEU A 398 SHEET 8 AA5 8 LEU A 377 TYR A 380 -1 N TYR A 380 O MET A 383 SHEET 1 AA6 2 VAL A 360 GLU A 361 0 SHEET 2 AA6 2 LYS A 364 SER A 365 -1 O LYS A 364 N GLU A 361 SHEET 1 AA7 6 LYS B 70 PHE B 71 0 SHEET 2 AA7 6 TYR B 63 LEU B 65 -1 N TYR B 63 O PHE B 71 SHEET 3 AA7 6 ALA B 50 GLN B 57 -1 N GLN B 57 O ASP B 64 SHEET 4 AA7 6 ASP B 40 ARG B 47 -1 N VAL B 45 O THR B 52 SHEET 5 AA7 6 SER B 28 PRO B 33 -1 N SER B 28 O ARG B 46 SHEET 6 AA7 6 TYR B 100 PRO B 101 1 O TYR B 100 N PHE B 29 SHEET 1 AA8 5 PHE B 113 GLY B 115 0 SHEET 2 AA8 5 PHE B 135 GLU B 139 1 O GLU B 139 N GLY B 115 SHEET 3 AA8 5 PHE B 147 THR B 153 -1 O SER B 150 N LEU B 136 SHEET 4 AA8 5 LYS B 166 CYS B 174 -1 O VAL B 170 N LEU B 149 SHEET 5 AA8 5 TYR B 179 ASP B 180 -1 O ASP B 180 N ARG B 173 SHEET 1 AA9 2 MET B 202 VAL B 203 0 SHEET 2 AA9 2 VAL B 209 LEU B 210 -1 O LEU B 210 N MET B 202 SHEET 1 AB1 2 ILE B 221 ASN B 222 0 SHEET 2 AB1 2 ASP B 487 ILE B 488 -1 O ILE B 488 N ILE B 221 SHEET 1 AB2 9 ARG B 289 VAL B 291 0 SHEET 2 AB2 9 TYR B 304 ILE B 310 -1 O ALA B 307 N VAL B 290 SHEET 3 AB2 9 TYR B 327 THR B 330 -1 O TYR B 327 N ILE B 310 SHEET 4 AB2 9 VAL B 455 HIS B 458 1 O VAL B 457 N ILE B 328 SHEET 5 AB2 9 VAL B 352 MET B 355 1 N VAL B 354 O VAL B 456 SHEET 6 AB2 9 ARG B 413 PHE B 420 1 O TYR B 418 N ILE B 353 SHEET 7 AB2 9 TYR B 396 LYS B 405 -1 N LEU B 403 O ARG B 413 SHEET 8 AB2 9 MET B 383 ALA B 392 -1 N ARG B 384 O SER B 404 SHEET 9 AB2 9 LEU B 377 TYR B 380 -1 N LYS B 378 O VAL B 385 SHEET 1 AB3 2 VAL B 360 GLU B 361 0 SHEET 2 AB3 2 LYS B 364 SER B 365 -1 O LYS B 364 N GLU B 361 CRYST1 55.150 83.280 218.940 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018132 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012008 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004567 0.00000